Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Ability of Vaped Marijuana to Reduce the Severity of Naloxone-Precipitated Withdrawal

NCT05114460 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT05114460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05114460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Ability of Vaped Marijuana to Reduce the Severity of Naloxone-Precipitated Withdrawal
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 2
Overall status
Terminated
Start date
November 1, 2021
Completion date
October 29, 2024
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid overdose